Detalles de la búsqueda
1.
Safety and Immunogenicity of a Recombinant Adenovirus Type-5-Vectored Coronavirus Disease 2019 (COVID-19) Vaccine With a Homologous Prime-Boost Regimen in Healthy Participants Aged ≥6 Years: A Randomized, Double-Blind, Placebo-Controlled, Phase 2b Trial.
Clin Infect Dis
; 75(1): e783-e791, 2022 08 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-34551104
2.
Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial.
Lancet
; 395(10240): 1845-1854, 2020 06 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-32450106
3.
Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial.
Lancet
; 396(10249): 479-488, 2020 08 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32702299
4.
Immunization With a Novel Human Type 5 Adenovirus-Vectored Vaccine Expressing the Premembrane and Envelope Proteins of Zika Virus Provides Consistent and Sterilizing Protection in Multiple Immunocompetent and Immunocompromised Animal Models.
J Infect Dis
; 218(3): 365-377, 2018 07 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29617816
5.
Toll-like receptor 4 signalling regulates antibody response to adenoviral vector-based vaccines by imprinting germinal centre quality.
Immunology
; 155(2): 251-262, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29876918
6.
Safety and immunogenicity of a recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in Sierra Leone: a single-centre, randomised, double-blind, placebo-controlled, phase 2 trial.
Lancet
; 389(10069): 621-628, 2017 02 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-28017399
7.
An Adenovirus Vaccine Expressing Ebola Virus Variant Makona Glycoprotein Is Efficacious in Guinea Pigs and Nonhuman Primates.
J Infect Dis
; 214(suppl 3): S326-S332, 2016 10 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-27493239
8.
Safety and immunogenicity of a novel recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in China: preliminary report of a randomised, double-blind, placebo-controlled, phase 1 trial.
Lancet
; 385(9984): 2272-9, 2015 Jun 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-25817373
9.
Enhanced neuroprotective activity of ophthalmic delivered nerve growth factor conjugated with cell penetrating peptide against optic nerve injury.
J Drug Target
; 32(1): 93-99, 2024 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-38105766
10.
Microparticulated Polygonatum sibiricum polysaccharide shows potent vaccine adjuvant effect.
Int J Pharm
; 652: 123802, 2024 Mar 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-38218508
11.
Rapid, sensitive, and convenient detection of Plasmodium falciparum infection based on CRISPR and its application in detection of asymptomatic infection.
Acta Trop
; 249: 107062, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37923286
12.
A causal multiomics study discriminates the early immune features of Ad5-vectored Ebola vaccine recipients.
Innovation (Camb)
; 5(3): 100603, 2024 May 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38745762
13.
Regulated control of virus replication by 4-hydroxytamoxifen-induced splicing.
Front Microbiol
; 14: 1112580, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36992923
14.
Effects of SARS-CoV-2 Omicron BA.1 Spike Mutations on T-Cell Epitopes in Mice.
Viruses
; 15(3)2023 03 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-36992472
15.
Lung-Targeted Transgene Expression of Nanocomplexed Ad5 Enhances Immune Response in the Presence of Preexisting Immunity.
Engineering (Beijing)
; 2023 Jan 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-36714358
16.
A seroepidemiological survey of adenovirus type 7 circulation among healthy adults in China and in Sierra Leone, West Africa.
Front Public Health
; 11: 1095343, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36815162
17.
Safety, immunogenicity and protection of heterologous boost with an aerosolised Ad5-nCoV after two-dose inactivated COVID-19 vaccines in adults: a multicentre, open-label phase 3 trial.
Lancet Infect Dis
; 23(10): 1143-1152, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37352880
18.
Immunization against Zika by entrapping live virus in a subcutaneous self-adjuvanting hydrogel.
Nat Biomed Eng
; 7(7): 928-942, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36959404
19.
Antibody persistence and safety after heterologous boosting with orally aerosolised Ad5-nCoV in individuals primed with two-dose CoronaVac previously: 12-month analyses of a randomized controlled trial.
Emerg Microbes Infect
; 12(1): 2155251, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36503413
20.
Safety and immunogenicity of heterologous boosting with orally aerosolised or intramuscular Ad5-nCoV vaccine and homologous boosting with inactivated vaccines (BBIBP-CorV or CoronaVac) in children and adolescents: a randomised, open-label, parallel-controlled, non-inferiority, single-centre study.
Lancet Respir Med
; 11(8): 698-708, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37209700